TRA-100 Trenbolone Acetate Oil Steroids Injectable 100mg/ml

Description

Trenbolone Acetate Short-Ester Injectable 19-nor Research

Pharmacodynamics

The pharmacology of Trenbolone Acetate is defined by its trienic bond structure at carbons 9 and 11, which precludes aromatization and enhances receptor affinity. Trenbolone molecules activate the nuclear androgen receptor (AR) to trigger the translocation of the receptor complex into the cellular nucleus. Androgen signaling suppresses glucocorticoid receptor activity, effectively inhibiting catabolic pathways and promoting a positive nitrogen balance. The ligand-AR complex initiates myogenic gene transcription by binding to androgen response elements (AREs), up-regulating localized IGF-1 expression. Binding kinetics indicate a high affinity for the AR with a Ki value of approximately 1.2 nM. Quantitatively, the terminal half-life of the acetate ester is approximately 48 hours (±6 hours), necessitating frequent titration. Compared to Trenbolone Enanthate, the acetate variant contains approximately 87% active steroid by weight, offering a more acute metabolic stimulus.

Compound Background

Trenbolone Acetate is a potent 19-nortestosterone (19-nor) derivative and synthetic parenteral AAS engineered for high-affinity receptor binding and robust anabolic signaling. Trenbolone Acetate binds to the nuclear androgen receptor (AR) with significantly higher affinity than native testosterone. Researchers prioritize this short-estered formulation for investigating acute tissue remodeling and the modulation of nutrient partitioning in advanced biological models. By utilizing an acetate ester, this compound ensures rapid systemic bioavailability and efficient receptor saturation.

Specification Sheet

• CAS Number: 10161-34-9
• Molecular Formula: C20H24O3
• Molecular Weight: 312.41 g/mol
• Appearance: Clear to pale amber viscous oil solution
• Purity: >99% confirmed via HPLC-UV and GC/MS
• Solubility: Optimized in organic carrier lipids including Grapeseed Oil and Ethyl Oleate

Experimental Outcomes

• Accelerated Protein Accrual: Study findings show rapid increases in lean body mass and skeletal muscle density over short 8-week research phases.
• Lipolytic Pathway Stimulation: Based on community feedback, effects include significant reductions in subcutaneous fat through AR-mediated lipolysis.
• Enhanced Nutrient Partitioning: Experimental findings suggest a profound improvement in feed efficiency, allowing for lean tissue preservation during caloric restriction.
• Positive Nitrogen Flux: Observed effects include a 50-60% improvement in nitrogen retention compared to baseline controls in metabolic studies.
• Myofibrillar Hardening: Users report a distinct increase in muscular hardness and vascularity within 7 to 10 days of administration.

Summary:
Trenbolone Acetate remains a premier research tool for studying advanced anabolic signaling and nutrient partitioning with rapid pharmacokinetic clearance.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.